BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $31.2 million versus the consensus estimate of $27.55 million.

GUIDANCE:

BioLife Solutions sees FY2021 revenue of $108-117 million, versus the consensus of $110 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.